Highlights Pharma Mar, S.A.

Equities

PHM

ES0169501022

Market Closed - BME Other stock markets 11:35:25 2024-05-20 am EDT			After market 01:47:24 pm
35.94 ^EUR	-2.12%		35.89	-0.14%

Apr. 23	Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Feb. 29	Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Pharma Mar Partner Wins Approval for Lung Cancer Drug in Macao	Dec. 04	MT
Pharma Mar's Partner Wins Commercialization Approval for Zepzelca in Peru	Nov. 07	MT
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Pharma Mar, S.A. commences an Equity Buyback Plan, under the authorization approved on May 31, 2023.	23-09-05	CI
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-27	CI
Ex-dividend day for final dividend	23-06-06	FA
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Pharma Mar Wins Conditional Approval For Lung Cancer Drug In Israel	23-01-31	MT
Pharma Mar, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Klaria Pharma, Pharma Mar to Collaborate on Feasibility Study	22-10-07	MT
Pharma Mar's Partner Wins Conditional Marketing Nod In South Korea For Small Cell Lung Cancer Drug	22-09-23	MT
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-27	CI
Pharma Mar, S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-27	CI
Ex-dividend day for final dividend	22-07-12	FA
Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Pharma Mar, S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-28	CI
Spain's PharmaMar raises dividend despite 32% drop in 2021 profit	22-02-28	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pharma Mar, S.A.

Equities

PHM

ES0169501022

Highlights

Filters